Manage Account - Modern Medicine
Triptans Associated with Rare Cases of Serotonin Syndrome
Even when used as monotherapy, triptans linked to potentially serious complications

Triptans -- serotonin-receptor agonists used to treat migraines -- are linked to uncommon but potentially serious cases of serotonin syndrome, according to a letter published in the May 15 issue of the New England Journal of Medicine.

The journal page you requested is now available only to registered Modern Medicine members.

Register Here

Registration is Free!
(and Takes Less than a Minute)

RegisterUS Physicians, click here
for express registration.

RegisterHealthcare Professionals,
click here

Modern Medicine Offers:
» Practice Management Advice
» CME / ICD-9 Coding / Formulary
» Patient Education Handouts
» Peer-reviewed Articles
» Conference Coverage, Email Alerts & More

Click Here to Watch the Tour

Already Registered?

Login Now

Login Email:Password:
Forgot Your Password?Remember me.

Click here